Transcatheter aortic valve replacement (TAVR) has now become the predominant therapy
for isolated, severe aortic stenosis.
1
TAVR volume now exceeds all forms of surgical aortic valve replacement (SAVR) and
can be performed with a 30-day mortality of 2.5%.
1
Conversion to SAVR during TAVR occurs in only 0.4% of patients.
1
Nevertheless, catastrophic complications can still occur during a TAVR. In this issue
of the Canadian Journal of Cardiology, Liang et al. report the incidence, outcomes, and management of catastrophic cardiac
events in patients undergoing TAVR from 2015 to 2019 at the University of Texas Health
Science Center in Houston, Texas, and review their strategies for dealing with these
complications.
2
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.Ann Thorac Surg. 2021; 111: 701-722
- Catastrophic cardiac events during transcatheter aortic valve replacement.Can J Cardiol. 2021; 37: 1522-1529
- Incidence, predictors, impact, and treatment of vascular complications after transcatheter aortic valve implantation in a modern prospective cohort under real conditions.J Vasc Surg. 2020; 72: 2120-2129
- Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17,919 patients.Eur Heart J. 2016; 37: 2240-2248
- Favorable impact of stents following emergent coronary artery bypass for failed angioplasty.Ann Thorac Surg. 1999; 68: 1644-1647
Article info
Publication history
Published online: May 03, 2021
Accepted:
April 21,
2021
Received:
April 19,
2021
Footnotes
See article by Liang et al., pages 1522–1529 of this issue.
See page 1501 for disclosure information.
Identification
Copyright
© 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Catastrophic Cardiac Events During Transcatheter Aortic Valve ReplacementCanadian Journal of CardiologyVol. 37Issue 10
- PreviewPerioperative complications of transcatheter aortic valve replacement (TAVR) are decreasing but can be catastrophic when they occur. Systematic reports of the nature of these events are lacking in the contemporary era. Our study aimed to report the incidence, outcomes, and perioperative management of catastrophic cardiac events in patients undergoing TAVR and to propose a working strategy to address these complications.
- Full-Text
- Preview
